Vascular endothelial growth factor-1 (VEGF-1) acts as endogeneous angiopoetic and neuroprotective factor. The aim of the study: to investigate an interrelationship between VEFG-1 elevation and neurologic recovery in short-term period among patients with ischemic hemispheric stroke. Methods: Seventy eight patients with ischemic hemispheric stroke were included in the study. Neurological impairment at presentation was assessed according National Institute of Health Stroke Scale. The Barthel Index and the modified Rankin Scale (mRS) were used to assess functional disability. Concentrations of VEGF-1 were measured at baseline using ELISA laboratory kit. Results: The total prevalence of hypertension was 100% (78 patients). 79.5% patients had dyslipidemia, 18% were diabetic, 15.4% of the total population was smokers. Among study patient population a total of 19.2% subjects had a past history of ischemic heart diseases in their families and 11.5% had experienced a previous ischemic heart episode. Within 6 month after baseline the favorable neuro-10 S.A. Medvedkova logic recovery defined as mRS ≤2 was found in 64 patients (82.1%). We calculated Modified Rankin Score ≥3 in 14 patients (17.9%). Depending on Modified Rankin Score at 6 month (≤2 and ≥3) we have divided all patients into two sub-groups respectively. We found a higher prevalence of subjects with dyslipidemia (P=0.044), diabetes mellitus (P=0.024), smokers (P=0.025) and as well as those with ischemic heart disease in their family histories (P=0.026) and previous ischemic heart episode (P=0.032) in subgroup with mRS≥3. At baseline VEGF-1 concentration in entire patient cohort was 348.55 pg/mL (IQR=241.70-493.80 pg/mL). We found higher VEGF-1 level in mRS ≥3 vs mRS ≤2 population sub-groups (P<0.05). Using multivariate Cox regression analysis we reported that VEGF-1 (increased per 125 pg / mL) and type two diabetes mellitus (present versus absent) were found as independent predictors for favorable neurologic recovery. In conclusion, we found that VEGF-1 (increased per 125 pg / mL) measured at baseline positively predicts improved neurologic recovery at six month among subjects with acute ischemic stroke who were not enrolled for invasive or thrombolytic strategy. Type two diabetes mellitus (present versus absent) were found as independent predictor for favorable neurologic recovery in follow up period.
Introduction
The stroke is the third most important reason of death of people in Ukraine (111.0 cases in 100 thousands of the population in 2014) and it remains to be the leading reason of the disability patients. Because of the improving of the level of the first aid, received by patients, more and more of them survive after the stroke, what demands an effective strategy and measures for the optimization of the results of the postapoplectic recovery and the decreasing of the level of the disability [2, 3] . The rehabilitation after a stroke is a difficult biological process with many factors, which influence the recovery processes. In recent years the knowledge about rehabilitation after a stroke has been considerably extended due to the made pre-clinical and clinical tests [4] . New technologies can give additional opportunities in treatment besides usual therapy [5, 6] . A lot of researches are dedicated to the rehabilitation of patients after strokes [7, 8] , but the main factors, which influence the recovery of postapoplectic patients in the early rehabilitation period, are not completely studied. Still there are open questions about the optimal intensity, «measuring», the duration of rehabilitation activities after a stroke in connection to the risk of the repeated acute break of cerebral blood circulation or other cardio-vascular events [9] . That's why the study of the role of biomarkers for the determination of the individual approach to the treatment-rehabilitation measures for the patients with cerebral ischemic stroke, to the monitoring of the patient's reaction to the made therapy and for the prognostication of the functional outcome of the disease, also of the risks of acute cerebral-cardial events is of current importance in the early recovery period.
Influence of the vascular remodelling and intensity …
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The aim of the research
To determine the influence of vascular remodeling and intensity of the neoangiogenesis on the outcome of the early recovery period by the patients with cerebral hemisphere ischemic stroke (CHIS).
The materials and approaches of the study
The complex, clinical-instrumental study and treatment of 78 patients in the early recovery period of cerebral hemisphere ischemic stroke has been made in the clinic of nervous diseases of the Zaporozhye State Medical University, 58 from them (74,3%) were men and 20 (25,7%) were women, whose average age was 58,5±0,9 years. The subtype of the ischemic stroke has been determined based on the TOAST-criteria [10] .
The criteria of the including were: men and women in the age of 30 years and older; patients with cerebral ischemic hemisphere stroke in the early recovery period; the signed informative agreement for the participation in the study.
The criteria of the exclusion: somatic diseases in the decompensation stage (noncontrolled arterial hypertension, sub-and decompensated insular diabetes; serious diseases of liver and kidneys); tumorous new formations; hemorrhagic stroke; ischemic subtentorial stroke; acute abnormalities of cerebral blood circulation in the anamnesis; endured cardiac infarction during 30 days before the including to the study; neurological disorders, which obstruct the research (expressed cognitive and / or depressive disorders, dysphasia, dyslexia). Such points were valued by us: the severity level of CHIS according to National Institutes of Health Stroke Scale (NIHSS) [11] , the level of invalidization and functional independency according to Modified Rankin Scale (mRS) [12] , Barthel Index (BI) [13] in dynamics on the 10 th , 30 th , 90 th , 180 th day of the disease. All the patients received spiral computer tomography of the encephalon on the device "Somatom Spirit" (Siemens, Germany), duplex scanning of main arteries of the head and neck on the ultrasonic scan "SSA-660 Xario" of Toshiba (Japan) according to the traditional approach in the debut of the disease.
The blood examples for the determination of the levels of vascular endothelial factor of the growth-1 were taken on the 10 th , 30 th and 180 th day of the disease. VEGF-1 was defined by the ELISA-method with the usage of commercial laboratory sets made by Bioscience (USA) due to the instruction of the company-producer.
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The functional outcome of the early recovery period of CHIS was estimated on the 180 th day of the disease according to mRS, herewith the relatively propitious outcome corresponded to the complete or partial recovery of the disrupted functions and the ability to work (≤2 points in mRS on the 180 th day of CHIS), relatively inauspicious functional outcome conformed the gently expressed disability without the renewal of the ability to work (≥3 points in mRS on the 180 th day of CHIS).
The clinical events, which could influence the functional outcome of the early recovery period of CHIS, were recorded (recurrent stroke; abnormalities of the heart rate, the ischemic disease of the heart, appeared for the first time, hypertension stroke, acute arterial/venous thrombosis, first appeared pancreatic diabetes). Such things as the age, the gender, the subtype of the stroke, the pace of the development, terms of hospitalization, the structure of the debut, reference values according to NIHSS, mRS, BI, the lateralization of the affection, the volume of the lesion focus according to the data of the computer tomography, the severity of arterial hypertension, vascular factors of risk, the abuse of alcohol, smoking, the presence of pancreatic diabetes, the hyperlipidemia, the body-mass index, the data of Doppler examination of the main head arteries, the vascular endothelial growth factor-1) were considered as potential factors, which could be associated with the beginning of the above mentioned cumulated clinical events.
Statistical analysis
The statistical calculations were made with the IBM statistical package Statistical Package for Social Sciences (SPSS), version 20. The normal distribution test was carried out with the Shapiro-Wilk test. The continuous variables followed a normal and abnormal distribution were expressed as mean (M) and average standard deviation (SD) and median (Me) and interquartile range (IQR). Categorical variables were expressed with frequencies in percentages. To compare the qualitative variables the Chi2 test and the Fisher exact test were applied. The analysis of the two independent samples was made with the Student´s t-test (normal distribution) or the Mann-Whitney U test. Age-and sex adjusted univariate and multivariate regression analysis for neurologic recovery defined as Modified Rankin Score ≤2 at 6 month. In the Cox regression model the significance of Odds Ratios (OR) was tested on the basis of Wald statistics. A two-tailed probability value of <0.05 was considered as significant.
Results and discussion
In the entire group of the CHIS patients there were 29 (37.2%) with the stroke in the right hemisphere, 49 (62.8%) -with the stroke in the left hemisphere. Cerebral atherosclerosis and hypertensive disease, which were determined by 78 (100%) and 77 (98.7%) patients accordingly, dominated as etiological factors. The duration of arterial hypertension was 5 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] years, the maximum levels of systolic arterial blood pressure (SABP) were 180 [160-211] mm Hg, the maximum levels of diastolic arterial blood pressure (DABP) were 100 [100-110] mm Hg. According to the TOAST-criteria 47.4% of patients had athero-thrombolytical subtype of the stroke, 41.0% -had lacunar subtype, 11,6% -had the stroke of unclear etiology.
By the analysis of the start term of the disease it was found out, that CHIS developed in a day-time by 79,5% of patients, by 16,7% -after sleep and by only 3,8% -during their sleep. 32,1% of patients were delivered into the department of acute abnormalities of cerebral blood circulation during first 6 hours from the beginning of the disease, 16,7% of patients were brought during 6-12 hours, 21,8% of patients -during 12-24 hours. The debut of the disease by 85.9% of patients was represented by the development of the isolated nidal neurological deficit and only in 11.5% of cases it was represented by its combination with general cerebral syndrome. The rate of development in main cases was gradual (65.4%). By the screening tests of 78 patients with CHIS on the 10 th day of the disease it was determined, that the value of the median of the total scores according to NIHSS was 5.0 [3.25-7 .75], it was 3.0 [2.00-3.00] according to mRS, it was 70 [60.00-85.00] according to BI.
Such remedies were used in the rehabilitation measures: pathogenic-drived remedies (hypotensive, anti-aggregate medicine, statins, medicines, which improve coronary blood circulation and metabolism in the cardiac muscle, anti-arrhythmic, anti-diabetic etc. according to the indications), adjuvant remedies (which improve metabolism and micro-circulation in the tissues of cerebrum), symptomatic remedies (neuromuscular relaxants, resolving medicines, anabolic hormones, neuro-psychotropic medicines, analgesics). Besides the drug therapy non-medical approaches of treatment were used, such as: Therapeutic physical training: treatment by placing, individual classes, training of right walking; mechanic therapy with the usage of table training simulators for palms and fingers, special devices for reduction of muscular tonus; Physiotherapy: massage of segmental zones, selective and punctuated massage of paretic extremities, apparatus physiotherapy (only after the adaptation of the patient and stabilization of his condition) -electrophoresis with vascular medicines on the cervical zone in order to improve the cerebral blood flow, electrophoresis of potassium or magnesium according to the method of Vermel by the abnormalities of heart rate; warmth on the paretic extremities by the increasing of muscular tonus, local anaesthetic procedures by arthralgia;
Psychotherapy: autogenic training, psychogymnastics;
Other special methods of treatment: trainings in speech therapy, obstructions of spastic muscles, acupuncture. The relatively propitious outcome of early recovery period by CHIS in form of the value of the total score according to mRS on the 180 th day -≤2 points -was determined by 82,1% of patients, the relatively inauspicious outcome in form of the value of the total score according to mRS on the 180 th day -≥3 points -was determined by 17,9% of patients. The generalized results of clinical-laboratory-instrumental researches of the patients on the 10 th day are represented in Table 1 , and the dynamics of the clinical-neurological abnormalities is placed in Table 2 .
At baseline VEGF-1 concentration in entire patient cohort was 348.55 pg/mL (IQR=241.70-493.80 pg/mL). There was significant difference between VEGF-1 in both population sub-groups at baseline (Figure 1 ). Higher VEGF-1 level was found in mRS ≥3 vs mRS ≤2 population sub-groups (P<0.05). At 10th, 30th, 180th day VEGF-1 concentrations appeared to be higher in mRS >3 compared with mRS <2 units (Figure 2 ). Age-and sex adjusted univariate regression analysis has shown that VEGF-1were determined as predictors for neurologic recovery defined as Modified Rankin Score ≤2 at 6 month. However, after including in multivariate regression model all variables with p value <0.2, we found that VEGF-1, dyslipidemia, and type two diabetes mellitus has remained independent predictors for favorable neurologic recovery. Table 3 shows the results of the Multivariate Cox regression analysis for favorable neurologic recovery (Modified Rankin Score ≥3 vs Modified Rankin Score ≤2). As one can see, VEGF-1 (increased per 125 pg / mL) and type two diabetes mellitus (present vs absent) were found as independent predictors for favorable neurologic recovery. Such clinical events, which could be associated with the start of the relatively inauspicious outcome (in all 48 events) were determined by 41 patients in the dynamics of the early recovery period of CHIS: the repeated stroke with lethal outcome (1.3%) and without it (5.1%); abnormalities of the heart rate (7.7%); first appeared ischemic disease of the heart, which was followed by the hospitalization in the in-patient department (2.6%), and without it (7.7%%); hypertension stroke, which was followed by the hospitalization in the in-patient department (2.6%), and without it (26.9%); acute arterial/ venous thrombosis, which was followed by the hospitalization in the in-patient department (1.3%), and without it (1.3%); first appeared pancreatic diabetes (3.8%). Nevertheless, the reliable predictors of this response are not fully determined. Our findings indicate that increased circulating level of peak VEGF-1 in acute stroke patients without severe disability might be discussed a marker for faster recovery of function within 6 month. This biomarker associated with low grade Modified Rankin Score at 6 month, while type two diabetes mellitus required to be taken into consideration as the second independent predictor. In is noted that the results were receive using age-and sex adjusted multivariable analysis that explain lack of serious impact of these important variables on risk of faster recovery. We did not find similar data in recently published reports. However, we believe that more investigations need to explain these findings and clear the role and underlying molecular effect of exaggerated level of VEGF-1 in ischemic stroke subjects. Because of a significant recovery in impaired functional domains can be expected during neuropsychological rehabilitation, treatment strategy based on measurements of circulating VEGF-1 could be appeared attractive. Whether measurement of circulating VEGF-1 may help to predict cognition impairment is not fully understood and it is required more scrutinizes.
Conclusions
The determination of VEGF-1-level on the 10 th , 30 th , 180 th day of the disease helps to work out an individual approach to the rehabilitation treatment of the patients with CHIS, to define its intensity and duration, taking in consideration the risk of the repeated acute abnormality of cerebral blood circulation and possible cardio-vascular events, to monitor the reaction of a patient on some types of therapy, to predict the functional outcome of the early recovery period. The developed strategies of the rehabilitation not only make it more effective, efficient, but also influence the economical aspect of the problem.
Limitations of the study
This study has some limitations. We relied on clinical data to rule out infection and other inflammatory diseases before sampling, but we cannot exclude that some patients had unrecognized conditions responsible for the elevated VEGF-1 levels observed. However, additional verification of atherosclerosis as well as intra-cranial artery occlusive disease can be required. We supposed that these limitations might not have a significant influence to study data interpretation
